Drug intelligence / Profile preview

2'-fluoro-2'-deoxyuridine 3'-monophosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** 2'-fluoro‑2'-deoxyuridine 3′‑monophosphate is a synthetic nucleoside monophosphate analog of deoxyuridine in which the hydrogen at the ribose sugar's C‑position is replaced by fluorine. It belongs to the class of pyrimidine antimetabolites and is structurally related to floxuridine (FUDR), a prodrug of fluorouracil. The compound acts as an inhibitor of thymidylate synthase by mimicking natural nucleotide substrates and interfering with DNA synthesis. This mechanism underlies its potential as an experimental antimetabolite for research into cancer therapeutics and possibly antimicrobial activity[1][7][8]. **Mechanism of Action:** - Inhibits thymidylate synthase by acting as a fraudulent nucleotide substrate. - Interferes with DNA synthesis through inhibition of dTMP production. - May be incorporated into nucleic acids or act as a precursor for further phosphorylated metabolites that disrupt cell proliferation[7][8].

Other names
1-(2-deoxy–fluoro–O-phosphono-beta-L-ribofuranosyl)pyrimidine–dione
02

Targets

TS (Thymidylate synthase)

Beyond the preview

Go deeper on 2'-fluoro-2'-deoxyuridine 3'-monophosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-fluoro-2'-deoxyuridine 3'-monophosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call